U.S. FDA authorizes Novavax COVID vaccine for adults
Go back to U.S. FDA authorizes Novavax COVID vaccine for adults| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.60 +0.05 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.55 | 52 Week High | $9.23 | |||
| Open | $10.43 | 52 Week Low | $1.16 | |||
| Day High | $10.85 | P/E | N/A | |||
| Day Low | $10.38 | EPS | $-0.30 | |||
| Volume | 4,341,717 | |||||

